For research use only
| Cat No. | ABC-TC3672 |
| Product Type | Hepatic Cells |
| Cell Type | Fibroblast |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Liver |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The Human Liver Fibroblasts from normal tissue, cultured in gelatin-coated flasks, passage 1,cryopreserved at ≥0.5×10⁶ cells/mL for liver disease modeling.
Human Liver Fibroblasts are spindle-shaped mesenchymal cells isolated from normal adult liver parenchyma. They exhibit adherent growth and express vimentin and Thy-1 (CD90). Karyotype analysis shows a normal human diploid complement. Functionally, the cells synthesize extracellular-matrix proteins—predominantly collagens types I and III and fibronectin—under basal conditions and are strongly up-regulated by TGF-β1, IL-1β, or IL-4 signaling pathways, whereas IFN-γ suppresses collagen output, reflecting fibroblast response to liver damage. These activities model hepatic wound healing and fibrogenesis relevant to liver cirrhosis and fibroblasts as well as chronic hepatitis progression. Cultures are non-tumorigenic, display a finite lifespan and cannot be serially passaged. To ensure the quality of these primary cells, repeated freeze-thaw cycles are not recommended due to the fragile nature of these cells. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human liver fibroblasts, Liver fibroblasts human |
| Species | Human |
| Cat.No | ABC-TC3672 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Liver |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Hepatic Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Liver Fibroblasts serve as relevant in vitro models for studying hepatic fibrosis, tissue remodeling, and inflammatory signaling in chronic liver diseases. They are widely used to investigate extracellular matrix (ECM) production, TGF-β signaling pathways, and hepatocyte-stromal interactions. These cells also provide a relevant platform for evaluating anti-fibrotic drugs, toxicology profiling, and regenerative medicine strategies targeting liver repair and scarring. Their human origin ensures translational relevance in preclinical research.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Liver Fibroblasts (NASH) can generally be expanded for 3–5 passages under AcceGen’s recommended culture conditions.